Stack Financial Management Inc Makes New Investment in Cardinal Health, Inc. $CAH

Stack Financial Management Inc acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 103,893 shares of the company’s stock, valued at approximately $24,681,000. Cardinal Health accounts for approximately 1.9% of Stack Financial Management Inc’s investment portfolio, making the stock its 21st biggest position.

Other institutional investors have also recently made changes to their positions in the company. Integrated Wealth Concepts LLC grew its position in Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Cardinal Health in the second quarter worth about $1,935,000. Cerity Partners LLC boosted its stake in shares of Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after acquiring an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC boosted its stake in shares of Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 1.6%

CAH stock opened at $234.92 on Friday. Cardinal Health, Inc. has a 12-month low of $145.87 and a 12-month high of $258.30. The business’s 50-day moving average is $230.30 and its 200 day moving average is $217.14. The stock has a market cap of $54.64 billion, a price-to-earnings ratio of 32.49, a PEG ratio of 1.37 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 12.52 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio is currently 28.49%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CAH shares. JPMorgan Chase & Co. lifted their price target on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday. Morgan Stanley increased their price target on Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Wednesday. Barclays raised their price objective on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday. UBS Group boosted their price objective on Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Leerink Partners set a $292.00 target price on Cardinal Health in a research note on Tuesday. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $265.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.